Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wakino

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Human Hypertension|August 6, 2004
Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal diseaseK Homma, K Hayashi, T Kanda, et al.
The Journal of Biological Chemistry|April 15, 2000
Tumor necrosis factor alpha inhibits insulin-induced mitogenic signaling in vascular smooth muscle cellsS Goetze, U Kintscher, H Kawano, et al.
Gerontology|January 1, 1996
Evidence for 54-kD protein in chicken kidney as a cytochrome P450 with a high molecular activity of 25-hydroxyvitamin D3 1 alpha-hydroxylaseS Wakino, M Meguro, H Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoterH L Brenza, C Kimmel-Jehan, F Jehan, et al.
Biochemical and Biophysical Research Communications|November 5, 1997
Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3 1 alpha-hydroxylaseT Monkawa, T Yoshida, S Wakino, et al.
Kidney International|December 9, 1998
Two novel 1alpha-hydroxylase mutations in French-Canadians with vitamin D dependency rickets type I1T Yoshida, T Monkawa, H S Tenenhouse, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulatorsS Wakino, U Kintscher, S Kim, et al.
Biochemical and Biophysical Research Communications|August 31, 2001
Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulatorsF Yin, S Wakino, Z Liu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient miceA R Collins, W P Meehan, U Kintscher, et al.
European Journal of Pharmacology|August 11, 2000
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytesU Kintscher, S Goetze, S Wakino, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Human Hypertension|August 6, 2004
Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal diseaseK Homma, K Hayashi, T Kanda, et al.
The Journal of Biological Chemistry|April 15, 2000
Tumor necrosis factor alpha inhibits insulin-induced mitogenic signaling in vascular smooth muscle cellsS Goetze, U Kintscher, H Kawano, et al.
Gerontology|January 1, 1996
Evidence for 54-kD protein in chicken kidney as a cytochrome P450 with a high molecular activity of 25-hydroxyvitamin D3 1 alpha-hydroxylaseS Wakino, M Meguro, H Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoterH L Brenza, C Kimmel-Jehan, F Jehan, et al.
Biochemical and Biophysical Research Communications|November 5, 1997
Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3 1 alpha-hydroxylaseT Monkawa, T Yoshida, S Wakino, et al.
Kidney International|December 9, 1998
Two novel 1alpha-hydroxylase mutations in French-Canadians with vitamin D dependency rickets type I1T Yoshida, T Monkawa, H S Tenenhouse, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulatorsS Wakino, U Kintscher, S Kim, et al.
Biochemical and Biophysical Research Communications|August 31, 2001
Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulatorsF Yin, S Wakino, Z Liu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient miceA R Collins, W P Meehan, U Kintscher, et al.
European Journal of Pharmacology|August 11, 2000
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytesU Kintscher, S Goetze, S Wakino, et al.
Pageof 3